Device type · QZI
Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
QZI
Cardiovascular
Device class
Class III
FDA decisions since 2015
8
510(k), De Novo and PMA
Adverse event reports
5,769
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation
- Product code
- QZI
- Device class
- Class III
- Review panel
- Cardiovascular
- Specialty
- Cardiology, Electrophysiology
- FDA record
- Classification database entry for QZI
Latest FDA decisions
- FARAPULSE Pulsed Field Ablation System (FARAWAVE Pulsed Field Ablation Catheter, FARAWAVE NAV Pulsed Field Ablation CPMA supplement
P230030-S012 · Decided Jan 12, 2026 · 201 days after receipt · Panel Track
Device type: Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation (QZI) · Cardiology
P250022 · Decided Dec 19, 2025 · 175 days after receipt
Device type: Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation (QZI) · Cardiology
P240044 · Decided Aug 27, 2025 · 253 days after receipt
Device type: Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation (QZI) · Cardiology
- FARAPULSE Pulsed Field Ablation System (FARAWAVE Pulsed Field Ablation Catheter, FARAWAVE NAV Pulsed Field Ablation CPMA supplement
P230030-S007 · Decided Jul 3, 2025 · 220 days after receipt · Panel Track
Device type: Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation (QZI) · Cardiology
- VARIPULSE Platform (VARIPULSE Catheter; TRUPULSE Generator; Sterile Interface Cable; nGEN Pump)PMA
P240006 · Decided Nov 6, 2024 · 231 days after receipt
Device type: Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation (QZI) · Cardiology
P240013 · Decided Oct 24, 2024 · 196 days after receipt
Device type: Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation (QZI) · Cardiology
- FARAPULSE Pulsed Field Ablation System (FARAWAVE Pulsed Field Ablation Catheter, FARASTAR Catheter Connection Cable,BreakthroughPMA
P230030 · Decided Jan 30, 2024 · 137 days after receipt
Device type: Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation (QZI) · Cardiology
- PulseSelect Pulsed Field Ablation (PFA) systemBreakthroughPMA
P230017 · Decided Dec 13, 2023 · 222 days after receipt
Device type: Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation (QZI) · Cardiology
Reports received
5,769
Received Nov 1, 2025 to Nov 19, 2026. Includes 40 of another or unstated type.
Malfunction reports
2,695
47% of reports
Injury reports
2,903
50% of reports
Death reports
131
2.3% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 25 | 29 | 0 | 0 |
| Mar 24 | 38 | 24 | 0 | 0 |
| Apr 24 | 65 | 32 | 0 | 0 |
| May 24 | 78 | 33 | 3 | 0 |
| Jun 24 | 52 | 38 | 1 | 0 |
| Jul 24 | 91 | 47 | 0 | 0 |
| Aug 24 | 101 | 33 | 3 | 0 |
| Sep 24 | 69 | 36 | 4 | 0 |
| Oct 24 | 99 | 62 | 5 | 0 |
| Nov 24 | 144 | 51 | 4 | 0 |
| Dec 24 | 168 | 90 | 5 | 0 |
| Jan 25 | 136 | 85 | 4 | 0 |
| Feb 25 | 157 | 99 | 5 | 0 |
| Mar 25 | 182 | 108 | 4 | 1 |
| Apr 25 | 191 | 112 | 10 | 0 |
| May 25 | 189 | 147 | 13 | 0 |
| Jun 25 | 171 | 161 | 6 | 0 |
| Jul 25 | 195 | 169 | 13 | 0 |
| Aug 25 | 209 | 179 | 12 | 0 |
| Sep 25 | 196 | 162 | 7 | 1 |
| Oct 25 | 206 | 177 | 15 | 1 |
| Nov 25 | 198 | 163 | 7 | 0 |
| Dec 25 | 208 | 219 | 12 | 0 |
| Jan 26 | 176 | 189 | 14 | 0 |
| Feb 26 | 214 | 182 | 10 | 0 |
| Mar 26 | 261 | 302 | 18 | 0 |
| Apr 26 | 198 | 293 | 11 | 0 |
| May 26 | 243 | 244 | 5 | 0 |
| Jun 26 | 232 | 286 | 11 | 0 |
| Jul 26 | 242 | 284 | 8 | 0 |
| Aug 26 | 223 | 203 | 8 | 16 |
| Sep 26 | 241 | 284 | 20 | 14 |
| Oct 26 | 259 | 254 | 7 | 10 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Boston Scientific2,545
- Medtronic2,397
- Abbott201
- Unk1
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem2,369
- Material Deformation394
- Entrapment of Device383
- Patient Device Interaction Problem372
- Device Contamination with Chemical or Other Material362
- Contamination294
- Material Twisted/Bent291
- Off-Label Use288
- Nonstandard Device189
- Fluid/Blood Leak129
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions2,704
- Pericardial Effusion497
- Low Blood Pressure/ Hypotension412
- Cardiac Tamponade354
- Stroke/CVA347
- Heart Block254
- Non specific EKG/ECG Changes236
- Bradycardia195
- Syncope/Fainting184
- Tachycardia162
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- FARASTAR Ablation Generator EU, Pulsed Field Ablation Generator, Product ID 61M401; Percutaneous Cardiac Ablation CatheterOpen, Classified
Z-2750-2026 · Started Jun 11, 2026 · Posted by FDA Jul 17, 2026
Reason given: Labeling discrepancy: Devices distributed with Instructions For Use (IFU) did not include FARAPOINT PFA catheter information.
Cause as FDA categorized it: Under Investigation by firm
- FARASTAR Pulsed Field Ablation Generator, Product ID M004PFCE61M401; Percutaneous Cardiac Ablation CatheterOpen, Classified
Z-2751-2026 · Started Jun 11, 2026 · Posted by FDA Jul 17, 2026
Reason given: Labeling discrepancy: Devices distributed with Instructions For Use (IFU) did not include FARAPOINT PFA catheter information.
Cause as FDA categorized it: Under Investigation by firm
- FARASTAR PFA Generator, Product ID M004PFCE61M460; Percutaneous Cardiac Ablation CatheterOpen, Classified
Z-2752-2026 · Started Jun 11, 2026 · Posted by FDA Jul 17, 2026
Reason given: Labeling discrepancy: Devices distributed with Instructions For Use (IFU) did not include FARAPOINT PFA catheter information.
Cause as FDA categorized it: Under Investigation by firm
- FARASTAR Ablation Generator EU, Pulsed Field Ablation Generator, Product ID 61M401; Percutaneous Cardiac Ablation CatheterOpen, Classified
Z-2753-2026 · Started Jun 11, 2026 · Posted by FDA Jul 17, 2026
Reason given: Boston Scientific is replacing specific FARASTAR PFA generators which have a configuration that is not compatible for use with the FARAPOINT PFA catheter.
Cause as FDA categorized it: Under Investigation by firm
Z-2278-2025 · Started Jun 25, 2025 · Posted by FDA Aug 8, 2025
Reason given: The potentially impacted units were manufactured using specific equipment that may have caused cracks in the electrode bands on the catheter's distal end.
Cause as FDA categorized it: Nonconforming Material/Component
Z-1205-2025 · Started Jan 5, 2025 · Posted by FDA Feb 28, 2025
Reason given: Due to an observed trend of neurovascular events
Cause as FDA categorized it: Labeling design
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.